Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
Pluristem's Cell Therapy For Bone Marrow A Blockbuster In The Making
Seeking Alpha
Wed, 08/8/12 - 12:04 pm
Pluristem
Amgen
AstraZeneca
Celgene
Dendreon
Eli Lilly
Medivation
Merck
Onyx
Pfizer
bone marrow disorder
Was MedImmune worth $15.6 billion?
Washington Post, DC
Mon, 08/6/12 - 11:44 am
MedImmune
AstraZeneca
The Cheapest, Dividend-Paying Major Drug Manufacturers
Seeking Alpha
Fri, 08/3/12 - 11:13 am
AstraZeneca
GSK
Eli Lilly
Sanofi
Vertex's Cystic Fibrosis Pipeline Offers Sales Upside
Seeking Alpha
Thu, 08/2/12 - 10:22 am
cystic fibrosis
Vertex Pharma
AstraZeneca
Gilead
Kalydeco
Pfizer
Rigel Pharmaceuticals
VX-809
Rigel's Drug Trials Offer Upside Through 2013
Seeking Alpha
Tue, 07/31/12 - 07:09 pm
Rigel Pharmaceuticals
Abbott Labs
Amgen
AstraZeneca
Roche Building On Its Strengths
Seeking Alpha
Mon, 07/30/12 - 11:44 am
Roche
Abbott Labs
AstraZeneca
Gilead
Complete Genomics
Sanofi
Pfizer
Pacific Biosciences
JNJ
Novartis
Illumina
GSK
Generics knock AstraZeneca Q2 earnings by 24 pct
Yahoo/AP
Thu, 07/26/12 - 09:24 am
earnings
AstraZeneca
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Mon, 07/23/12 - 09:15 am
drug approvals
earnings
Amylin
InterMune
Human Genome Sciences
GSK
Bristol-Myers Squibb
Questcor
BiogenIdec
Alexion
Regeneron
Eli Lilly
Amarin
Horizon Pharma
Celgene
Amgen
Gilead
Alkermes
United Therapeutics
Roche
Sanofi
Merck
AstraZeneca
Salix
Progenics Pharmaceuticals
AstraZeneca backs $12M round for upstart's self-assembling drug pipeline
Fierce Biotech
Wed, 07/18/12 - 12:59 pm
AstraZeneca
MedImmune Ventures
Ascent Biomedical Ventures
Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now?
Seeking Alpha
Wed, 07/18/12 - 12:27 pm
Pluristem Therapeutics
Alkermes
AstraZeneca
Bristol-Myers Squibb
Isis Pharmaceuticals
Eli Lilly
Momenta
Merck
Pfizer
Sanofi
Spectrum Pharmaceuticals
AstraZeneca Expands Study Of Brilinta Against Plavix
Bloomberg
Tue, 07/17/12 - 10:47 am
AstraZeneca
Plavix
Brilinta
bloodthinners
Ex-AstraZeneca chief forfeits up to £3.5M in exit pay
Fierce Pharma
Mon, 07/16/12 - 07:36 pm
executive pay
AstraZeneca
David Brennan
Profit From GlaxoSmithKline's Mistake
Seeking Alpha
Fri, 07/13/12 - 01:23 pm
GSK
Amylin
AstraZeneca
Merck
Novartis
Pfizer
The Challenges in Staying #1 in Big Pharma
Forbes
Fri, 07/13/12 - 01:22 pm
Merck
Novartis
Pfizer
AstraZeneca
AstraZeneca acquires neuroscience assets from Link Medicine
Yahoo/Fly on the Wall
Thu, 07/12/12 - 12:34 pm
Link Medicine
AstraZeneca
M&A
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:47 pm
Xenon
Virobay
Tolero Pharmaceuticals
Threshold Pharmaceuticals
Novartis
Merck KGaA
Merck
MannKind
licensing
Janssen
Isis Pharmaceuticals
Ironwood
Inhibrx Thrombogenics
GSK
Genmab
Genentech
Galapagos
Forma Therapeutics
Endocyte
Endo
Enanta
Celgene
Bristol-Myers Squibb
Boehringer Ingelheim
Bionomics
Biogen Idec
BioDelivery Sciences
AstraZeneca
Angiochem
AC Immune
Abbott Laboratories
LEO Pharma
Novartis: Buy Before The Bullish Rally
Seeking Alpha
Mon, 07/9/12 - 10:40 am
Novartis
Pfizer
JNJ
AstraZeneca
Amylin Deal Signals Diabetes Space is Hot
Motley Fool
Fri, 07/6/12 - 07:34 pm
diabetes
Amylin
M&A
Bristol-Myers Squibb
AstraZeneca
Seven pharma companies partner with Gates Foundation to speed TB drug discovery
Yahoo/Fly on the Wall
Fri, 07/6/12 - 12:45 pm
tuberculosis
Bill Gates
Abbott Laboratories
AstraZeneca
Bayer
Eli Lilly
GSK
Merck
Sanofi
Big Pharma’s Big Fines
ProPublica.org
Thu, 07/5/12 - 05:16 pm
fines
whistleblower lawsuits
Eli Lilly
Pfizer
AstraZeneca
Merck
Abbott Laboratories
GSK
Pages
« first
‹ previous
…
116
117
118
119
120
121
122
123
124
…
next ›
last »